News Blog

News Blog


As the First H1N1 human vaccine trials get underway, the U.S. earmarks $1.8 billion for the flu's anticipated resurgence

first h1n1 vaccine trialsThe first vaccines against H1N1 in humans will be put to the test starting tomorrow. The Australia-based pharmaceutical company CSL, Ltd., will commence the trials in Adelaide by giving 240 healthy volunteers the shot, Bloomberg News reported today.

“The world will be watching to see the immunogenicity results of this first clinical trial,” the World Health Organization (WHO) director of vaccine research told Bloomberg. The crucial result she refers to is exactly how much antigen it will take to fend off the virus. And that amount, the report notes, will provide more concrete data about how many doses companies will be able to make this year. The WHO has recommended that when a vaccine does become available, healthcare workers be the first in line to receive it.

The U.S. Food and Drug Administration (FDA) yesterday approved the seasonal flu vaccine for this fall. It won’t protect against the H1N1 virus, the agency noted in a statement, but the traditional flu still kills about 36,000 people in the U.S. each year. The FDA noted that it “continues to work with manufacturers, international partners and other government agencies to facilitate the availability of a safe and effective vaccine against the 2009 H1N1 virus.” October has been offered as a goal to have the first courses of the vaccine syringe-ready in the U.S.

President Barack Obama warned earlier this month of the need to be vigilant for a resurgence of the virus in the early fall, as it has continued to spread through the summer. He has since authorized $1.825 billion in emergency funds for flu prevention and treatment.  

Meantime, the WHO conceded in a statement last week that, “further spread of the pandemic, within affected countries and to new counties, is considered inevitable.” Given that and the “unprecedented speed” of the spread (covering the globe in six weeks rather than six months, as in past influenza pandemics), the agency has stopped tallying cases. As of first week of July—just 10 weeks since the U.S. first declared a public health emergency over “swine flu”—the WHO had reported more than 94,000 confirmed cases of the flu worldwide and at least 400 deaths.

Image courtesy of iStockphoto/svengine

Tags: H1N1, vaccine
More News Blog: Next: Watchdogs: Feds buried data proving that handheld tech dangerously distracts drivers Previous: New Jersey beaches: Sun, sand, surf--and E. coli?

2 Comments

Add Comment
View
  1. 1. Quinn the Eskimo 01:57 AM 7/24/09

    So far, and this may change, the H1N1 is far less lethal than the average flu. Let's hope it stays that way.

    Still, at 60, I'll get the shots. You should seriously consider doing so too.

    Reply | Report Abuse | Link to this
  2. 2. jh443 04:53 AM 7/24/09

    That this latest outbreak of H1N1 was far less contagious and lethal than the 1918 pandemic should be proof enough that there are far more important factors to influenza than its protein shell. How much effort is being devoted to determining what these factors are?? Once identified, precise calculations could be made concerning the impact that the H5N1 "avian flu" would actually have on the population once it does eventually cross the species barrier. And, who knows, identifying these factors might also reveal a new method of combating it.

    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

See what we're tweeting about

Scientific American Editors

More »

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital
  SA Digital

Science Jobs of the Week

Email this Article

As the First H1N1 human vaccine trials get underway, the U.S. earmarks $1.8 billion for the flu's anticipated resurgence: Scientific American Blog

X
Scientific American Magazine

Subscribe Today

Save 66% off the cover price and get a free gift!

Learn More >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X

About the Bering in Mind Blog

In this column presented by Scientific American Mind magazine, research psychologist Jesse Bering of Queen's University Belfast ponders some of the more obscure aspects of everyday human behavior. Ever wonder why yawning is contagious, why we point with our index fingers instead of our thumbs or whether being breastfed as an infant influences your sexual preferences as an adult? Get a closer look at the latest data as "Bering in Mind" tackles these and other quirky questions about human nature. Sign up for the RSS feed or friend Dr. Bering on Facebook and never miss an installment again.

X

About the Cross-check Blog

Every week, John Horgan takes a puckish, provocative look at breaking science. A former staff writer at Scientific American, he is the author of several books—most notably, The End of Science: Facing the Limits of Knowledge in the Twilight of the Scientific Age. He currently directs the Center for Science Writings at Stevens Institute of Technology. He lives in New York State's Hudson Highlands, where he plays ice hockey each winter to hone his cross-checking skills.

X

Expeditions Blog

Ever wonder what it's really like to be working in Antarctica or collecting core samples from the middle of the Pacific Ocean? Get a first-hand feel for scientific exploration by following the blog posts of researchers out in the field.

X

About the Extinction Countdown Blog

Several times a week, John Platt shines a light on endangered species from all over the globe, exploring not just why they are dying out but also what's being done to rescue them from oblivion. From unusual or little-known organisms like the giant spitting earthworm and the stinking hawk's-beard to popular favorites like cheetahs and koalas, Platt, a journalist specializing in environmental issues and technology, does his part to slow the countdown.

X

About the Guest Blog

The editors of Scientific American regularly encounter perspectives on science and technology that we believe our readers would find thought-provoking, fascinating, debatable and challenging. The guest blog is a forum for such opinions. The views expressed belong to the author and are not necessarily shared by Scientific American.

X

About the Solar at Home Blog

Follow Scientific American editor George Musser as he installs--or tries to install--solar photovoltaic panels on the roof of his suburban New Jersey home. You'll learn the literal nuts and bolts of going green with the sun and get energy-saving tips even if you aren't putting up panels.

Write to us with tips or comments at blog@sciam.com and follow us on Twitter: http://twitter.com/sciam.

X